Nouvelle déclaration d'incident
No de la demande: 2025-6327
Numéro de référence du titulaire d'homologation: 2025-US-023177, 023185
Nom du titulaire (nom légal complet, aucune abbréviation): Farnam Companies, Inc.
Adresse: 711 E. Missouri Avenue, Suite 200
Ville: Phoenix
État: Arizona
Pays: United States of America
Code postal /Zip: 85014-2863
Incident chez un animal domestique
Pays: UNITED STATES
État: OREGON
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. 270-304-89459
Nom du produit: ADAMS Botanicals Flea and Tick Cat and Home Spray
Liquide
Oui
Inconnu
Site: Animal / Usage sur un animal domestique
Autre
Cat / Chat
Domestic Shorthair
1
Femme
0.91
7
lbs
Cutanée
>24 hrs <=3 days / >24 h <=3 jours
>8 hrs <=24 hrs / > 8 h < = 24 h
Système
Persisted until death
Non
Non
Mort
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
On 05-Aug-2025, a 11 month old, approximately 7 pound, intact, female, Domestic Shorthair cat, in unknown condition, with concomitant medical conditions of fleas and flea anemia, was administered an unknown amount of ADAMS Botanicals Flea and Tick Cat and Home Spray (Pyrethrins) via the topical route by the animal tender (foster). On approximately 06-Aug-2025, the cat developed lethargy. The animal tender initially attributed the cat's lethargy to flea-bite anemia, and continued to manually remove fleas from the cat, but the lethargy continued to worsen throughout the day. Later that day the cat's signs progressed to weakness, inability to stand (Unable to rise), tremors, dilated pupils, loss of consciousness (Unconscious), and lack of a response to stimuli. On 07-Aug-2025, all clinical signs progressed and the cat died at home. No veterinary medical intervention was sought out and no at-home care was provided. No further information is expected.
Mort
Assessment: This product contains pyrethrins in very low concentration (0.1%) giving it a wide margin of safety, even in cats. While cats are more sensitive to pyrethroid insecticides than other mammals, this concentration is not expected to cause systemic toxicity or neurological signs. Even if ingested, only mild GI upset would be anticipated. This cat had known underlying fleas and flea-bite anemia. Severe anemia can lead to lethargy, weakness, loss of consciousness (due to lack of oxygen to the brain) and eventually death. Without veterinary evaluation and diagnostics, including necropsy, the relationship between product use and outcome is inconclusive. The information contained in this report is based on self-reported statements provided to the registrant during telephone interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.
Autre
Cat / Chat
Domestic Shorthair
1
Homme
0.91
8
lbs
Cutanée
>24 hrs <=3 days / >24 h <=3 jours
>24 hrs <=3 days / >24 h <=3 jours
Système
Persisted until death
Non
Non
Mort
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
On 05-Aug-2025, a 11 month old, approximately 8 pound, neutered, male, Domestic Shorthair cat, in unknown condition, with concomitant medical conditions of fleas, was administered an unknown amount of ADAMS Botanicals Flea and Tick Cat and Home Spray (Pyrethrins) via the topical route by the animal tender (foster). On 07-Aug-2025, the cat was found deceased with no prior clinical signs noted. No further information is expected.
Mort
Assessment: This product contains pyrethrins in very low concentration (0.1%) giving it a wide margin of safety, even in cats. While cats are more sensitive to pyrethroid insecticides than other mammals, this concentration is not expected to cause systemic toxicity or neurological signs. Even if ingested, only mild GI upset would be anticipated. Other causes including underlying severe flea bite anemia, congenital conditions, infectious disease, and unknown trauma should also be considered. Without veterinary evaluation and diagnostics, including necropsy, the relationship between product use and outcome is inconclusive. The information contained in this report is based on self-reported statements provided to the registrant during telephone interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.